2019 Latest Design Toltrazuril Oral Solution & Suspension - Neomycin Sulfate Oral Solution – Jizhong
2019 Latest Design Toltrazuril Oral Solution & Suspension - Neomycin Sulfate Oral Solution – Jizhong Detail:
Neomycin Sulfate Oral Solution
Composition:
Contains per ml:
Neomycin Sulfate 200mg
Solvents ad 1ml
Description:
Neomycin has strong bactericidal effect on gram-negative bacillus.Internal use is rarely absorbed and is mostly excreted in its original form.Increased absorption occurs when the intestinal mucosa is inflamed or has an ulcer.
Indications:
For the treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to Neomycin sulfate in cattle( excluding veal calves), swine, sheep and goats.
Contra-indications:
Hypersensitivity to Neomycin.
Side effects:
Neomycin have nephrotoxicity, ototoxicity and neuromuscular blocking effect.
Dosage:
Calculated by Neomycin , mixed drinking, poultry 50-75mg, each 1L water for 3-5days.
Withdrawal times:
Chicken 5days. Forbidden using at egg laying.
Packaging:
Vial of 100ml.
Product detail pictures:
Related Product Guide:
We offer wonderful energy in high-quality and improvement,merchandising,product sales and marketing and advertising and procedure for 2019 Latest Design Toltrazuril Oral Solution & Suspension - Neomycin Sulfate Oral Solution – Jizhong , The product will supply to all over the world, such as: Romania, Albania, panama, our qualify products have good reputation from the world as its most competive price and our most advantage of after-sale service to the clients.we hope we can provide a safe, environmental products and super service to our clients from all of the world and establish strategic partnership with them by our professional standards and unremitting efforts.
By Liz from Slovenia - 2017.10.23 10:29
The factory workers have rich industry knowledge and operational experience, we learned a lot in working with them,we are extremely grateful that we can encount a good company has excellent wokers.
By Colin Hazel from United States - 2018.02.04 14:13